img

Global Tendonitis Treatment Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tendonitis Treatment Drug Market Research Report 2024

According to MRAResearch’s new survey, global Tendonitis Treatment Drug market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tendonitis Treatment Drug market research.
Key companies engaged in the Tendonitis Treatment Drug industry include Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Abbott, Pfizer, Bayer AG, GlaxoSmithKline, Almatica Pharma and Teva Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Tendonitis Treatment Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tendonitis Treatment Drug market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tendonitis Treatment Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
AstraZeneca
Boehringer Ingelheim Pharmaceuticals
Abbott
Pfizer
Bayer AG
GlaxoSmithKline
Almatica Pharma
Teva Pharmaceuticals
Segment by Type
Injection
Oral

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tendonitis Treatment Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tendonitis Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Tendonitis Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tendonitis Treatment Drug Market Perspective (2018-2033)
2.2 Tendonitis Treatment Drug Growth Trends by Region
2.2.1 Global Tendonitis Treatment Drug Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tendonitis Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Tendonitis Treatment Drug Forecasted Market Size by Region (2024-2033)
2.3 Tendonitis Treatment Drug Market Dynamics
2.3.1 Tendonitis Treatment Drug Industry Trends
2.3.2 Tendonitis Treatment Drug Market Drivers
2.3.3 Tendonitis Treatment Drug Market Challenges
2.3.4 Tendonitis Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tendonitis Treatment Drug Players by Revenue
3.1.1 Global Top Tendonitis Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Tendonitis Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Tendonitis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tendonitis Treatment Drug Revenue
3.4 Global Tendonitis Treatment Drug Market Concentration Ratio
3.4.1 Global Tendonitis Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tendonitis Treatment Drug Revenue in 2022
3.5 Tendonitis Treatment Drug Key Players Head office and Area Served
3.6 Key Players Tendonitis Treatment Drug Product Solution and Service
3.7 Date of Enter into Tendonitis Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tendonitis Treatment Drug Breakdown Data by Type
4.1 Global Tendonitis Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Tendonitis Treatment Drug Forecasted Market Size by Type (2024-2033)
5 Tendonitis Treatment Drug Breakdown Data by Application
5.1 Global Tendonitis Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Tendonitis Treatment Drug Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tendonitis Treatment Drug Market Size (2018-2033)
6.2 North America Tendonitis Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Tendonitis Treatment Drug Market Size by Country (2018-2023)
6.4 North America Tendonitis Treatment Drug Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tendonitis Treatment Drug Market Size (2018-2033)
7.2 Europe Tendonitis Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Tendonitis Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Tendonitis Treatment Drug Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tendonitis Treatment Drug Market Size (2018-2033)
8.2 Asia-Pacific Tendonitis Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Tendonitis Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Tendonitis Treatment Drug Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tendonitis Treatment Drug Market Size (2018-2033)
9.2 Latin America Tendonitis Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Tendonitis Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Tendonitis Treatment Drug Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tendonitis Treatment Drug Market Size (2018-2033)
10.2 Middle East & Africa Tendonitis Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Tendonitis Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Tendonitis Treatment Drug Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Tendonitis Treatment Drug Introduction
11.1.4 Merck Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.1.5 Merck Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Tendonitis Treatment Drug Introduction
11.2.4 AstraZeneca Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim Pharmaceuticals
11.3.1 Boehringer Ingelheim Pharmaceuticals Company Detail
11.3.2 Boehringer Ingelheim Pharmaceuticals Business Overview
11.3.3 Boehringer Ingelheim Pharmaceuticals Tendonitis Treatment Drug Introduction
11.3.4 Boehringer Ingelheim Pharmaceuticals Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.3.5 Boehringer Ingelheim Pharmaceuticals Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Tendonitis Treatment Drug Introduction
11.4.4 Abbott Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Tendonitis Treatment Drug Introduction
11.5.4 Pfizer Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Detail
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Tendonitis Treatment Drug Introduction
11.6.4 Bayer AG Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.6.5 Bayer AG Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Tendonitis Treatment Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Almatica Pharma
11.8.1 Almatica Pharma Company Detail
11.8.2 Almatica Pharma Business Overview
11.8.3 Almatica Pharma Tendonitis Treatment Drug Introduction
11.8.4 Almatica Pharma Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.8.5 Almatica Pharma Recent Development
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Company Detail
11.9.2 Teva Pharmaceuticals Business Overview
11.9.3 Teva Pharmaceuticals Tendonitis Treatment Drug Introduction
11.9.4 Teva Pharmaceuticals Revenue in Tendonitis Treatment Drug Business (2018-2023)
11.9.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tendonitis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Global Tendonitis Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Tendonitis Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Tendonitis Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Tendonitis Treatment Drug Market Share by Region (2018-2023)
Table 8. Global Tendonitis Treatment Drug Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Tendonitis Treatment Drug Market Share by Region (2024-2033)
Table 10. Tendonitis Treatment Drug Market Trends
Table 11. Tendonitis Treatment Drug Market Drivers
Table 12. Tendonitis Treatment Drug Market Challenges
Table 13. Tendonitis Treatment Drug Market Restraints
Table 14. Global Tendonitis Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Tendonitis Treatment Drug Market Share by Players (2018-2023)
Table 16. Global Top Tendonitis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tendonitis Treatment Drug as of 2022)
Table 17. Ranking of Global Top Tendonitis Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Tendonitis Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tendonitis Treatment Drug Product Solution and Service
Table 21. Date of Enter into Tendonitis Treatment Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tendonitis Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Tendonitis Treatment Drug Revenue Market Share by Type (2018-2023)
Table 25. Global Tendonitis Treatment Drug Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Tendonitis Treatment Drug Revenue Market Share by Type (2024-2033)
Table 27. Global Tendonitis Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Tendonitis Treatment Drug Revenue Market Share by Application (2018-2023)
Table 29. Global Tendonitis Treatment Drug Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Tendonitis Treatment Drug Revenue Market Share by Application (2024-2033)
Table 31. North America Tendonitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Tendonitis Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Tendonitis Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Tendonitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Tendonitis Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Tendonitis Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Tendonitis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Tendonitis Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Tendonitis Treatment Drug Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Tendonitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Tendonitis Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Tendonitis Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Tendonitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Tendonitis Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Tendonitis Treatment Drug Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Tendonitis Treatment Drug Product
Table 49. Merck Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 50. Merck Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Tendonitis Treatment Drug Product
Table 54. AstraZeneca Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Boehringer Ingelheim Pharmaceuticals Company Detail
Table 57. Boehringer Ingelheim Pharmaceuticals Business Overview
Table 58. Boehringer Ingelheim Pharmaceuticals Tendonitis Treatment Drug Product
Table 59. Boehringer Ingelheim Pharmaceuticals Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 60. Boehringer Ingelheim Pharmaceuticals Recent Development
Table 61. Abbott Company Detail
Table 62. Abbott Business Overview
Table 63. Abbott Tendonitis Treatment Drug Product
Table 64. Abbott Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Tendonitis Treatment Drug Product
Table 69. Pfizer Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bayer AG Company Detail
Table 72. Bayer AG Business Overview
Table 73. Bayer AG Tendonitis Treatment Drug Product
Table 74. Bayer AG Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 75. Bayer AG Recent Development
Table 76. GlaxoSmithKline Company Detail
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Tendonitis Treatment Drug Product
Table 79. GlaxoSmithKline Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Almatica Pharma Company Detail
Table 82. Almatica Pharma Business Overview
Table 83. Almatica Pharma Tendonitis Treatment Drug Product
Table 84. Almatica Pharma Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 85. Almatica Pharma Recent Development
Table 86. Teva Pharmaceuticals Company Detail
Table 87. Teva Pharmaceuticals Business Overview
Table 88. Teva Pharmaceuticals Tendonitis Treatment Drug Product
Table 89. Teva Pharmaceuticals Revenue in Tendonitis Treatment Drug Business (2018-2023) & (US$ Million)
Table 90. Teva Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tendonitis Treatment Drug Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Tendonitis Treatment Drug Market Share by Type: 2022 VS 2033
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Global Tendonitis Treatment Drug Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Tendonitis Treatment Drug Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Tendonitis Treatment Drug Report Years Considered
Figure 11. Global Tendonitis Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Tendonitis Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Tendonitis Treatment Drug Market Share by Region: 2022 VS 2033
Figure 14. Global Tendonitis Treatment Drug Market Share by Players in 2022
Figure 15. Global Top Tendonitis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tendonitis Treatment Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Tendonitis Treatment Drug Revenue in 2022
Figure 17. North America Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Tendonitis Treatment Drug Market Share by Country (2018-2033)
Figure 19. United States Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Tendonitis Treatment Drug Market Share by Country (2018-2033)
Figure 23. Germany Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Tendonitis Treatment Drug Market Share by Region (2018-2033)
Figure 31. China Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Tendonitis Treatment Drug Market Share by Country (2018-2033)
Figure 39. Mexico Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Tendonitis Treatment Drug Market Share by Country (2018-2033)
Figure 43. Turkey Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Tendonitis Treatment Drug Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 46. AstraZeneca Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 47. Boehringer Ingelheim Pharmaceuticals Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 48. Abbott Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 50. Bayer AG Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 52. Almatica Pharma Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Tendonitis Treatment Drug Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed